Food and therapeutic product interactions - A therapeutic perspective

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 12, Issue 3, 2009, Pages 367-377

  MacDonald, Laura ^a   Foster, Brian C ^a,b   Akhtar, Humayoun ^c  

^a HEALTH CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; CALCIUM ION; CIPROFLOXACIN; CYTOCHROME P450; EZETIMIBE; FEXOFENADINE; FISH OIL; FUROCOUMARIN; GENISTEIN; HERBACEOUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; ROSUVASTATIN; TAMOXIFEN; WARFARIN;

ADVERSE OUTCOME; APPLE JUICE; AREA UNDER THE CURVE; BLEEDING; CRANBERRY JUICE; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXCRETION; DRUG INHIBITION; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME INHIBITION; FOOD DRUG INTERACTION; FOOD PROCESSING; FOOD QUALITY; FOOD SAFETY; GRAPEFRUIT JUICE; HERB DRUG INTERACTION; HUMAN; IC 50; INTERNATIONAL NORMALIZED RATIO; MAXIMUM PLASMA CONCENTRATION; MOLECULAR INTERACTION; MYOPATHY; NEOPLASM; NONHUMAN; ORANGE JUICE; POMEGRANATE JUICE; PRACTICE GUIDELINE; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; SIDE EFFECT; TRANSIENT ISCHEMIC ATTACK; ANIMAL; BIOTRANSFORMATION; CLINICAL TRIAL; DRUG DOSAGE FORM; FUNCTIONAL FOOD; PHARMACOKINETICS; STANDARD;

ANIMALS; BIOTRANSFORMATION; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DOSAGE FORMS; FOOD-DRUG INTERACTIONS; FUNCTIONAL FOOD; HUMANS; PHARMACOKINETICS; RISK ASSESSMENT;

EID: 77950365044     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/J30P4C     Document Type: Review

References (43)

1. Thompson LU.; Ward WE., Food-Drug Synergy and Safety. CRC Press, Taylor and Francis, University of Toronto, ON, Canada, 2006.
2. Jefferson JW. Drug and diet interactions: avoiding therapeutic paralysis. J Clin Psychiatry, 1998; 59 Suppl 16:31-9.
3. Self TH, Chrisman CR, Baciewic AM, Brone MS. Isoniazid drug and food interactions. Am J Med Sci, 1999;317(5):304-11.
4. Singh BN. Effects of food on clinical pharmacokinetics. Clin Pharmacokinet., 1999; 37(3):213-55.
5. Lampe JW, Peterson S. Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr, 2002; 132(10):2991-4.
6. Sørensen JM. Herb-drug, food-drug, nutrientdrug, and drug-drug interactions: mechanisms involved and their medical implications. J Altern Complement Med, 2002; 8(3):293-308.
7. Harris R, Jang GR, Tsunoda S. Dietary effects on drug metabolism and transport. Clin Pharmacokinet, 2003; 42(13):1071-88.
8. Fujita K. Food-drug interactions via human cytochrome P450 3A (CYP3A). Drug Metabol Drug Interact, 2004; 20(4):195-217.
9. Scheen AJ. Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide. Clin Pharmacokinet, 2007; 46(2):93-108.
10. Akhtar, MH Food and drug interaction-a Growing concern. Pak J Sci Ind Res 2008; 51(4): 225-234.
11. Spinella M. The importance of pharmacological synergy in psychoactive herbal medicines. Altern Med Rev, 2002, 7:130-137.
12. Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine, 2001, 8:401-409.
13. Foster BC, Vandenhoek S, Hanna J, et al. Effects of natural health products on cytochrome P-450 drug metabolism. Phytomedicine, 2003;10 (4):334-342.
14. Sand PG, Dreiseitel A, Stang M, et al. Cytochrome P450 2C19 inhibitory activity of common berry constituents. Phytother Res, 2009 Jul 7. [doi.wiley.com/10.1002/ptr.2910]
15. Hermans K, Stockman D, Van den Branden F. Grapefruit and tonic: a deadly combination in a patient with the long QT syndrome. Am J Med, 2003; 114(6):511-512.
16. Guo LQ, Yamaoe Y. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Acta Pharmacol Sin, 2004; 25(2):129-136.
17. Fontana E, Dansette PM, Poli SM. Cytochrome P450 enzyme mechanism based inhibitors: common sub-strucutres and reactivity. Cur Drug Metab, 2005; 6:413-454.
18. Sakamaki N, Nakaato M, Matsumoto H, et al. Contents of furanocoumarins in grapefruit juice and health foods. Shokuhin Eiseigaku Asshi, 2008; 49(4):326-331.
19. Hidaka M, Fujita K, Ogikubo T, et al. Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity. Drug Metab Dispos, 2004; 32(6):581-583.
20. Sorokin AV, Duncan B, Panetta R, Thompson PD. Rhabdomyolysis associated with pomegranate juice consumption. Am J Cardiol, 2006; 98(5):705-706.
21. Faria A, Monteiro R, Aevedo I, Calhau C. Pomegranate juice effects on cytochrome P450S expression: in vivo studies. J Med Food, 2007; 10(4):643-9.
22. Saruwatari A, Okamura S, Nakajima Y, et al. Pomegranate juice inhibits sulfoconjugation in Caco-2 human colon carcinoma cells. J Med Food, 2008; 11(4):623-8.
23. Zhang JW, Liu Y, Cheng J, et al. Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharmaceut Sci, 2007; 10(4):496-503.
24. Dresser GK, Bailey DG, Leake BF, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther, 2002; 71(1):11-20.
25. Satoh H, Yamashita F, Tsujimoto M, et al. Citrus juices inhibit the function of human organic anion-transporting polypeptide OATPB. Drug Metab Dispos, 2005; 33(4):518-523.
26. Bartle WR, Ferland G. Fiddleheads and the international normalized ratio. N Eng J Med, 1998; 338(21):15-50.
27. Griffiths AP, Beddall A, Pegler S. Fatal haemopericardium and gastrointestinal haemorrhage due to possible interaction of cranberry juice with warfarin. J R Soc Promot Health, 2008; 128(6):324-326.
28. Huang YT, Onose J, Abe N, Yoshikawa K. In vitro inhibitory effects of pulvinic acid derivatives isolated from Chinese edible mushrooms, Boletus calopus and Suillus bovinus, on cytochrome P450 activity. Biosci Biotechnol Biochem, 2009; 23; 73(4):855-60.
29. James MO, Sacco JC, Faux LR. Effects of Food Natural Products on the Biotransformation of PCBs. Environ Toxicol Pharmacol, 2008; 25(2):211-217.
30. McClaskey EM, Michalets EL. Subdural hematoma after a fall in an elderly patient taking high-dose omega-3 fatty acids with warfarin and aspirin: case report and review of the literature. Pharmacother, 2007; 27(1):152-160.
31. Buckley MS, Goff AD, Knapp WE. Fish oil interaction with warfarin. Ann Pharmacother, 2004; 38(1):50-52.
32. Budharja V, Paul D. "Warfarin and flax seed oil interaction and a mechanism for interaction for polyunsaturated fatty acid" [linemed. files. wordpress. com/2008/2009/52-53. pdf]
33. Stoll, BA. Eating to beat breast cancer: potential role for soy supplements. Ann Onco, 1997; 8:223-225.
34. Ju YH, Doerge DR, Allred KF, et al. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res, 2002; 62(9):2474-2477.
35. Isoherranen N, Hachad H, Yeung CK, Levy RH. Qualitative analysis of the role of metabolites in inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction database. Chem Res Toxicol, 2009; 22(2):294-8.
36. Foster, BC, Arnason JT., Briggs, CJ. Natural health products and disposition. Ann Rev Pharmacol Toxicol, 2005, 45: 203-226.
37. Neuhofel AL, Wilton JH, Victory JM, et al. Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction. J Clin Pharmacol, 2002; 42:461-466.
38. Navarro AS, Cabarga MM, Hurle ADG. Comparative study of the influence of Ca2+ on absorption parameters of ciprofloxacin and ofloxacin. J Antimicrob Chemother, 1994; 34:119-125.
39. Wallace AW, Amsden GW. Is it really OK to take this with food? Old interactions with a new twist. J Clin Pharmacol, 2002; 42:437-443.
40. Shay NF, Ban WJ. Regulation of gene transcription by botanicals: novel regulatory mechanisms. Annu Rev Nutr, 2005; 25:297-315.
41. Burdge GC, Lillycrop KA, Jackson AA. Nutrition in early life, and risk of cancer and metabolic disease: alternative endings in an epigenetic tale? Br J Nutr. 2009; 101(5):619-30.
42. Nabekura T, Kamiyama S, Kitagawa S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem Biophys Res Commun, 2005; 18:327(3):866-70.
43. Guo LQ, Yamazoe Y. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Acta Pharmacol Sin. 2004; 25(2):129-36.